Civic Intelligence

Association for Accessible Medicines

990 • Fiscal year 2016 • EIN 52-2252820

Jan 01, 2016 to Dec 31, 2016

Organization ProfileWWW.ACCESSIBLEMEDS.ORG
Washington, DC
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

48th percentile

0.28x

Higher debt load relative to assets than 48% of similar nonprofits.

2016 filings • 501(c)6 • $10M-$25M nonprofits • Source year 2016

Liabilities / Revenue

24th percentile

0.18x

Higher debt load relative to revenue than 24% of similar nonprofits.

2016 filings • 501(c)6 • $10M-$25M nonprofits • Source year 2016

Net Margin

10th percentile

-9.6%

Higher net margin than 10% of similar nonprofits.

2016 filings • 501(c)6 • $10M-$25M nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

4th percentile

-15%

Faster asset growth than 4% of similar nonprofits.

2016 filings • 501(c)6 • $10M-$25M nonprofits • Annualized from 2015 to 2016

Revenue Growth

67th percentile

6.7%

Faster revenue growth than 67% of similar nonprofits.

2016 filings • 501(c)6 • $10M-$25M nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets48th percentile

Assets

Down

$11,233,560

Down $2,054,715 (-15%) from 2015

Net Assets

Down

$8,132,807

Down $1,687,973 (-17%) from 2015

Liabilities

Down

$3,100,753

Down $366,742 (-11%) from 2015

Revenue And Expenses
Liabilities / Revenue24th percentileNet Margin10th percentile

Revenue

Up

$17,562,967

Up $1,109,752 (+6.7%) from 2015

Expenses

Up

$19,250,940

Up $6,251,274 (+48%) from 2015

Net Income

Down

-$1,687,973

Down $5,141,522 (-149%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth4th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$30M$20M$10M$0Assets 2011: $4,828,357Liabilities 2011: $1,621,469Net Assets 2011: $3,206,8882011Assets 2012: $7,524,695Liabilities 2012: $2,240,844Net Assets 2012: $5,283,8512012Assets 2013: $8,665,416Liabilities 2013: $2,579,452Net Assets 2013: $6,085,9642013Assets 2014: $9,287,669Liabilities 2014: $2,920,438Net Assets 2014: $6,367,2312014Assets 2015: $13,288,275Liabilities 2015: $3,467,495Net Assets 2015: $9,820,7802015Assets 2016: $11,233,560Liabilities 2016: $3,100,753Net Assets 2016: $8,132,8072016Assets 2017: $11,655,437Liabilities 2017: $6,199,926Net Assets 2017: $5,455,5112017Assets 2018: $11,413,504Liabilities 2018: $6,594,852Net Assets 2018: $4,818,6522018Assets 2019: $13,682,968Liabilities 2019: $7,141,290Net Assets 2019: $6,541,6782019Assets 2020: $11,604,954Liabilities 2020: $4,151,968Net Assets 2020: $7,452,9862020Assets 2021: $18,090,132Liabilities 2021: $8,691,351Net Assets 2021: $9,398,7812021Assets 2022: $27,489,220Liabilities 2022: $20,279,874Net Assets 2022: $7,209,3462022Assets 2023: $23,610,075Liabilities 2023: $12,114,192Net Assets 2023: $11,495,8832023Assets 2024: $22,475,133Liabilities 2024: $7,732,655Net Assets 2024: $14,742,4782024

Highlighted filing

2016

Assets$11,233,560
Liabilities$3,100,753
Net Assets$8,132,807
Open 2016 Filing

Operations Trend

Revenue Growth67th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MExpenses 2011: $7,594,2282011Expenses 2012: $9,653,0232012Revenue 2013: $12,528,336Expenses 2013: $11,726,223Net Income 2013: $802,1132013Revenue 2014: $12,378,583Expenses 2014: $12,097,316Net Income 2014: $281,2672014Revenue 2015: $16,453,215Expenses 2015: $12,999,666Net Income 2015: $3,453,5492015Revenue 2016: $17,562,967Expenses 2016: $19,250,940Net Income 2016: -$1,687,9732016Revenue 2017: $24,822,702Expenses 2017: $27,499,998Net Income 2017: -$2,677,2962017Revenue 2018: $26,569,380Expenses 2018: $27,206,239Net Income 2018: -$636,8592018Revenue 2019: $30,972,110Expenses 2019: $29,249,084Net Income 2019: $1,723,0262019Revenue 2020: $25,540,449Expenses 2020: $24,629,141Net Income 2020: $911,3082020Revenue 2021: $25,522,984Expenses 2021: $23,573,545Net Income 2021: $1,949,4392021Revenue 2022: $22,662,006Expenses 2022: $24,851,441Net Income 2022: -$2,189,4352022Revenue 2023: $22,235,390Expenses 2023: $17,948,853Net Income 2023: $4,286,5372023Revenue 2024: $21,539,161Expenses 2024: $18,292,566Net Income 2024: $3,246,5952024

Highlighted filing

2016

Revenue$17,562,967
Expenses$19,250,940
Net Income-$1,687,973
Open 2016 Filing
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

The organization fosters and promotes the interests of the generic pharmaceutical and biosimilar industry.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$11,233,560
Liabilities
$3,100,753
Net assets
$8,132,807
Revenue
$17,562,967
Expenses
$19,250,940
Net income
-$1,687,973
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$22.5$7.73$14.7$21.5$18.3$3.25
2023Summary only. Only limited summary data is available for this year.$23.6$12.1$11.5$22.2$17.9$4.29
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$27.5$20.3$7.21$22.7$24.9$2.19
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$18.1$8.69$9.40$25.5$23.6$1.95
2020Facts available. Structured filing facts are available, but richer extracted sections are limited.$11.6$4.15$7.45$25.5$24.6$0.91
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$13.7$7.14$6.54$31.0$29.2$1.72
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$11.4$6.59$4.82$26.6$27.2$0.64
2017Summary only. Only limited summary data is available for this year.$11.7$6.20$5.46$24.8$27.5$2.68
2016Summary only. Only limited summary data is available for this year.$11.2$3.10$8.13$17.6$19.3$1.69
2015Detailed filing. Detailed filing data is available for this year.$13.3$3.47$9.82$16.5$13.0$3.45
2014Detailed filing. Detailed filing data is available for this year.$9.29$2.92$6.37$12.4$12.1$0.28
2013Detailed filing. Detailed filing data is available for this year.$8.67$2.58$6.09$12.5$11.7$0.80
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$7.52$2.24$5.28$9.65
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$4.83$1.62$3.21$7.59
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2016 filings • 501(c)6 • $10M-$25M nonprofits